Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEW-7197 pharmacokinetics under fed and fasting conditions
NCT03704675Phase 1Completed
- Sponsor
- MedPacto
- Start
- Aug 2018
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vactosertib in solid tumor (2 arms), sponsored by MedPacto. Primary endpoints: Maximum Concentration and Area Under the Concentration Curve. Started Aug 2018; status: completed.
02
Drugs
vactosertib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03704675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03704675.